Search

everythinglearnresearchcommunity

for

Search:↓

The ethanol patch test reliably identifies ALDH phenotype.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Plasma is better than Ringer's lactate for hair graft survival and growth after transplantation.

The buffy coat method slightly outperformed apheresis in patient-reported hair improvement for treating hair loss.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Autogenic and allogenic PRP effectively promote wound healing.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Histopathological confirmation is crucial for accurately diagnosing challenging alopecia areata cases.

OCT can detect hidden hair follicles in alopecia areata, indicating potential hair regrowth.

The trichogram is a practical, non-invasive, and cost-effective tool for diagnosing female androgenetic alopecia.

Candida antigen is an effective and promising treatment for alopecia areata.

Biocompatible artificial hair implants significantly improved patients' quality of life and were successful.

Transplanted hair follicles can resist hair loss from an autoimmune condition better than natural hair.

The 3D skin model is better for hair growth research and testing treatments.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

The conclusion compares the effectiveness of different hair transplant techniques.

Cross-section trichometry is an accurate method to measure hair loss and growth.

A hair test can accurately predict if a person with hair loss will respond to minoxidil treatment.

Platelet lysate is more effective than activated autologous platelet-rich plasma or saline in improving hair growth after hair restoration surgery.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Both bone donor sites had low long-term issues and high patient satisfaction.

A new model uses specific blood markers to predict if children's hair loss will return.

Adding Triamcinolone to the anesthetic can reduce swelling after hair transplants, and using Platelet-Rich Plasma can improve hair thickness and patient satisfaction. The SRD5A2 gene also plays a key role in the success of hair transplants.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Dermagraft and Dermalogen had a lot of granulation, while Alloderm, Integra, and ADM had good blood vessel growth for skin healing.

The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.